EUVIMEDEUVIMED entdecken
Crossref

Smoking cessation and atherosclerotic cardiovascular events and mortality in chronic kidney disease

Young Su Joo iD, Hae-Ryoung Yun, Hyung Woo Kim iD, Hee Byung Koh iD, Chan-Young Jung, Tae-Ik Chang iD, Jung Tak Park iD, Sue Kyung Park iD, Young Youl Hyun, Yeong Hoon Kim, Suah Sung, Tae-Hyun Yoo und 3 weitere

Nephrology Dialysis Transplantation · 30.05.2025 · 40 (6) · 1203-1212

DOI: 10.1093/ndt/gfae268 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Nephrology Dialysis Transplantation, online erschienen am 15.11.2024. Verfasst von Young Su Joo und 14 weiteren Autor:innen. Beteiligte Einrichtung: Department of Internal Medicine, College of Medicine, Institute of Kidney Disease Research, Yonsei University, Seoul, Korea. Hauptthemen laut MEDLINE: Smoking Cessation, Renal Insufficiency, Chronic, Atherosclerosis, Smoking. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 43 Literaturangaben. Gefördert von: Korea Disease Control and Prevention Agency.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Smoking cessation is recommended to reduce excess atherosclerotic cardiovascular disease (ASCVD) and mortality in patients with chronic kidney disease (CKD). However, this recommendation is largely based on observational studies on the general population Therefore, we aimed to evaluate the association of smoking dose and smoking cessation duration with ASCVD and mortality in patients with CKD.

Methods

We compiled a comprehensive pooled dataset comprising 66 245 participants with CKD from the KNOW-CKD and the UK Biobank cohort. Additionally, we included 307 353 participants without CKD from the UK Biobank cohort. Participants were categorized according to smoking dose and duration of smoking cessation base on a questionnaire. The primary outcome was a composite of ASCVD events or all-cause mortality.

Results

Over a median follow-up period of 13.2 years, 14 671 (22.1%) participants reached the primary outcome. In the pooled CKD cohort, compared to never smokers, and former and current smokers exhibited a 1.30- and 2.14-fold higher risk of the primary outcome, respectively. Among former smokers, the hazard ratios (HRs) (95% confidence intervals [CIs]) for smoking loads <20 and ≥20 pack-years were 1.05 (1.00–1.10) and 2.14 (2.05–2.25), respectively. The increased risk of the primary outcome was attenuated by longer smoking cessation. The HRs (95% CIs) for smoking cessation of <10 years, 10–20 years, and ≥20 years were 1.75 (1.65–1.86), 1.43 (1.34–1.52), and 1.11 (1.06–1.16), respectively, compared with never smokers. This association was also observed in individuals without CKD, but the risk was comparable between former smokers with smoking cessation ≥20 years and non-smokers, suggesting that a longer cessation is required in patients with CKD to offset the smoking-related adverse effects.

Conclusions

Among former smokers with CKD, the risk of ASCVD or mortality was substantially attenuated with less smoking load and a longer duration of smoking cessation.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Smoking CessationRenal Insufficiency, ChronicAtherosclerosisSmokingCardiovascular DiseasesHumansMaleFemaleMiddle AgedFollow-Up StudiesAgedPrognosisRisk FactorsSurvival RateGlomerular Filtration RateAdult

Stichwörter der Autor:innen

atherosclerotic cardiovascular diseasechronic kidney diseasesmoking cessation

Autor:innen und Institutionen

  • Department of Internal Medicine, College of Medicine, Institute of Kidney Disease Research, Yonsei University, Seoul, Korea.
  • Division of Nephrology, Department of Internal Medicine, Yongin Severance Hospital, Yonsei University College of Medicine, Yongin, Korea.
  • Institute for Innovation in Digital Healthcare, Yonsei University, Seoul, Korea.
  • Department of Internal Medicine, Catholic Kwandong University International Saint Mary's Hospital, Incheon, Korea.
  • Division of Nephrology, Department of Internal Medicine, Asan Medical Center, Seoul, Korea.
  • Department of Internal Medicine, National Health Insurance Service Medical Center, Ilsan Hospital, Goyang, Korea.

ORCID-Profile: Young Su Joo, Hyung Woo Kim, Hee Byung Koh, Tae-Ik Chang, Jung Tak Park, Sue Kyung Park, Seung Hyeok Han

Förderung

  • Korea Disease Control and Prevention Agency

Zitieren

APA

Joo, Y. S., Yun, H. R., Kim, H. W., Koh, H. B., Jung, C. Y., Chang, T. I., Park, J. T., Park, S. K., Hyun, Y. Y., Kim, Y. H., Sung, S., Yoo, T. H., Oh, K. H., Kang, S. W., & Han, S. H. (2025). Smoking cessation and atherosclerotic cardiovascular events and mortality in chronic kidney disease. Nephrology Dialysis Transplantation, 40(6), 1203-1212. https://doi.org/10.1093/ndt/gfae268

Vancouver

Joo YS, Yun HR, Kim HW, Koh HB, Jung CY, Chang TI, et al. Smoking cessation and atherosclerotic cardiovascular events and mortality in chronic kidney disease. Nephrology Dialysis Transplantation. 2025;40(6):1203-1212. doi:10.1093/ndt/gfae268

BibTeX
@article{Joo2025,
  author = {Joo, Young Su and Yun, Hae-Ryoung and Kim, Hyung Woo and Koh, Hee Byung and Jung, Chan-Young and Chang, Tae-Ik and Park, Jung Tak and Park, Sue Kyung and Hyun, Young Youl and Kim, Yeong Hoon and Sung, Suah and Yoo, Tae-Hyun and Oh, Kook-Hwan and Kang, Shin-Wook and Han, Seung Hyeok},
  title = {Smoking cessation and atherosclerotic cardiovascular events and mortality in chronic kidney disease},
  journal = {Nephrology Dialysis Transplantation},
  year = {2025},
  volume = {40},
  number = {6},
  pages = {1203--1212},
  doi = {10.1093/ndt/gfae268}
}
Kostenlos starten →